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Abstract: Human metapneumovirus (HMPV) is one of the major causes of acute respiratory tract 
infection (ARI) and shows high morbidity and mortality, particularly in children and immunocompromised 
patients. Various methods for detecting HMPV have been developed and applied in clinical laboratories. 
When reviewing the literature, we found that polymerase chain reaction (PCR)-based assays have been 
most frequently and consistently used to detect HMPV. The most commonly used method was multiplex 
reverse transcriptase-PCR (RT-PCR; 57.4%), followed by real-time RT-PCR (38.3%). Multiplex RT-PCR 
became the more popular method in 2011–2019 (69.7%), in contrast to 2001–2009 (28.6%). The advent of 
multiplex PCR in detecting broader viral pathogens in one run and coinfected viruses influenced the change 
in user preference. Further, newly developed microarray technologies and ionization mass spectrometry 
were introduced in 2011–2019. Viral culture (including shell vial assays) and fluorescent immunoassays (with 
or without culture) were once the mainstays. However, the percentage of studies employing culture and 
fluorescent immunoassays decreased from 21.4% in 2001–2010 to 15.2% in 2011–2019. Meanwhile, the use 
of PCR-based methods of HMPV detection increased from 78.6% in 2001–2010 to 84.8% in 2011–2019. 
The increase in PCR-based methods might have occurred because PCR methods demonstrated better 
diagnostic performance, shorter hands-on and run times, less hazards to laboratory personnel, and more 
reliable results than traditional methods. When using these assays, it is important to acquire a comprehensive 
understanding of the principles, advantages, disadvantages, and precautions for data interpretation. In 
the future, the combination of nanotechnology and advanced genetic platforms such as next-generation 
sequencing will benefit patients with HMPV infection by facilitating efficient therapeutic intervention. 
Analytical and clinical validation are required before using new techniques in clinical laboratories.
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Introduction
Human metapneumovirus (HMPV) is one of the main viral 
etiological agents of acute respiratory tract infection (ARI), 
which is a major cause of morbidity and mortality, especially 
in southeast Asia (1). HMPV was first discovered by genetic 
analysis of nasopharyngeal aspirate samples taken from 28 
hospitalized children in the Netherlands. These samples, 
taken from children with ARIs during the past 20 years, 
had symptoms ranging from mild respiratory problems to 
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severe cough, bronchiolitis, and pneumonia. Some of them 
were hospitalized and needed mechanical ventilation (2). 
Since then, HMPV has been detected in approximately 
6.39% of patients hospitalized with ARI (3). The prevalence 
of HMPV varied from 0% (4) to 36.4% (5), showing high 
heterogeneity in previous studies. HMPV is commonly 
found in children, particularly those less than 2 years old (6). 
HMPV infection has also affected immunocompromised 
patients such as elderly adults (7) and hematopoietic stem 
cell-transplant recipients (8). The HMPV outbreaks showed 
an overall fatality rate of 11% (9).
HMPV is an enveloped virus that is comprised of a 
negative-sense, single-stranded RNA genome. The HMPV 
genome harbors 8 genes that encode for 9 proteins. The 
order of these genes in the genome is N-P-M-F-M2-SH-
G-L. The encoded proteins include the nucleoprotein 
(N protein), phosphoprotein (P protein), matrix protein 
(M protein), fusion glycoprotein (F protein), putative 
transcription factor (M2-1 protein), RNA synthesis 
regulatory factor (M2-2 protein), small hydrophobic 
glycoprotein (SH protein), attachment glycoprotein (G 
protein), and viral polymerase (L protein) (10,11). The F, 
M, and L genes as well as the N gene (the most conserved 
region), have been targeted to detect HMPV by reverse 
transcriptase-polymerase chain reaction (RT-PCR) 
(12,13). In the past few decades, several methods have 
been developed and established for detecting HMPV (6). 
Traditional diagnostic techniques (such as virus culture) 
and immunoassays have been used for pathogen detection. 
Recently, the advent of newly developed assays utilizing 
melting-curve analysis, and nucleic acid-amplification 
technologies has enabled clinical laboratories to detect 
HMPV rapidly and precisely. When adopting these 
assays, the comprehensive understanding of the principles, 
advantages, disadvantages, and precautions for data 
interpretation should be well-informed. Articles focusing 
on laboratory methods for HMPV detection have seldomly 
been published. Therefore, we reviewed the laboratory 
assays used for HMPV in the real-world laboratories based 
on published articles.
RT-PCR
RT-PCR is commonly used to detect HMPV (Table 1). 
This technique involves the reverse transcription of RNA 
into complementary DNA (cDNA) and the amplification 
of specific DNA targets using PCR. Simultaneous 
performance of RT-PCR and real-time PCR, which enables 
combined nucleic acid amplification and detection in a 
single step, is routinely used to detect viral RNA (14).
Nucleic acid extraction and purification are basic steps 
used for most RT-PCR systems. The sample concentration 
can be measured to improve the clinical sensitivity. These 
procedures are automated in numerous laboratories for 
high-quality and reproducible results. The QIAamp viral 
RNA Mini Kit from Qiagen (15-17), the MagNaPure 
Compact system from Roche (18,19), and the NucliSENS 
easyMAG platform from bioMérieux (20,21) are widely used 
for automated RNA extraction from respiratory swabs or 
aspirate specimens. Including control material is necessary 
to validate the extraction and purification steps. Primers and 
probes enabling amplification and detection of viral targets 
have been reported (15,22,23). Primers against conserved 
regions have been preferred for reliable amplification or for 
identifying sequence variants. However, these primers can 
cause decreased amplification efficiency when homologous 
primers incorporate into products. Several HMPV genes 
such as P, M, F, or N have served as targets for RT-PCR. 
Among them, the N gene is most conserved and has shown 
high sensitivity and reliability for all four genotypes; thus, it 
has been widely targeted in RT-PCR assays (12,13,24).
The PCR thermal cycling programs consist of three 
steps (denaturation, annealing, and elongation) and are 
slightly varied, according to previous reports for HMPV 
(15,23). Quantification can be performed by RT-PCR 
as either a one-step or a two-step reaction (25). One of 
the main differences between these two procedures is 
the number of used tubes. For one-step RT-PCR, most 
processes going from the reverse transcriptase reaction to 
PCR amplification are conducted in a single tube. However, 
cDNA synthesis and PCR amplification occur in separate 
tubes in two-step reactions. The advantage of using a one-
step protocol is that it minimizes experimental variation. 
However, using RNA (which is prone to degradation) as the 
starting templates for one-step reactions makes it difficult to 
repeatedly assay the same samples over a period of time. In 
addition, one-step protocols are reported to be less sensitive 
than two-step protocols (26). Two-step reaction show high 
reproducibility and it is possible to perform several different 
PCR assays after diluting a single cDNA sample (27). 
Although two-step protocols are vulnerable to DNA 
contamination, they have been the preferred methods when 
using DNA-binding dyes such as SYBR Green. Primer 
dimers can be easily eliminated by manipulating the melting 
temperatures.
Gel-based detection (28), automated fluorescent capillary 
Annals of Translational Medicine, Vol 8, No 9 May 2020 Page 3 of 17




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Jeong et al. Advances in laboratory assays for HMPV 
© Annals of Translational Medicine. All rights reserved.   Ann Transl Med 2020;8(9):608 | http://dx.doi.org/10.21037/atm.2019.12.42







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Annals of Translational Medicine, Vol 8, No 9 May 2020 Page 5 of 17


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Jeong et al. Advances in laboratory assays for HMPV 
© Annals of Translational Medicine. All rights reserved.   Ann Transl Med 2020;8(9):608 | http://dx.doi.org/10.21037/atm.2019.12.42




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Annals of Translational Medicine, Vol 8, No 9 May 2020 Page 7 of 17
© Annals of Translational Medicine. All rights reserved.   Ann Transl Med 2020;8(9):608 | http://dx.doi.org/10.21037/atm.2019.12.42
electrophoresis (29), or hybridization to target specific 
probes (30) have been used to detect the amplified products. 
Nested PCR was adopted in several laboratories because of 
its enhanced sensitivity and specificity (31,32). However, 
problems with amplicon contamination have occurred even 
in experienced laboratories (33). As a preferred method in 
clinical laboratories, real-time PCR assays utilize target-
specific probes to detect the amplified products. Among 
various types of fluorescent probes used for real-time PCR, 
TaqMan and molecular beacon probes are most widely used. 
The fluorescent signals generated by TaqMan and molecular 
beacon probes depend on Förster resonance energy transfer 
(FRET)-based coupling of the dye molecule and a quencher 
moiety to the oligonucleotide substrate (34). During PCR 
amplification, TaqMan probes hybridize to the target 
sequences and cleave the fluorescent probe. Decoupling 
of the quencher molecule and the fluorescent probe 
increases the fluorescence intensity in direct proportion 
to the number of probes that are cleaved (35). TaqMan 
probes were frequently used to detect HMPV in previous 
studies (36-39). Molecular beacon probes also utilize FRET 
detection. However, they remain intact and rebind to a new 
target during each PCR cycle. When molecular beacon 
probes hybridize to a target, the fluorescent dye and the 
quencher are separated and emit fluorescent light upon 
excitation (40). Both TaqMan and molecular beacon probes 
are expensive and time-consuming to synthesize and require 
separate probes for each RNA target. HMPV detection 
was previously achieved using the NucliSENS EasyQ 
instrument (bioMérieux) and molecular beacon probes 
(3,41). The appropriateness of selecting the real-time 
amplification format for HMPV detection depends on the 
number of targets to be tested, laboratory throughput, level 
of expertise available, and acceptable hands-on or run time. 
The spectral overlap of fluorophores should be considered, 
especially for fluorescent real-time PCR assays. Checking 
the specificity of probe hybridization is recommended due 
to its usefulness and relative convenience.
Multiplex RT-PCR
In multiplex PCR, multiple primer sets are included 
within a single PCR tube to produce amplicons specific 
to different target sequences. The primer pairs should 
be optimally designed to function at the same annealing 
temperature. Different amplicons are detected using target-
specific probes labeled with different fluorescent dyes (42). 
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of respiratory viruses in a single test run. Additionally, 
information pertaining to coinfection can be obtained 
through multiplex PCR (35,43). A 30% to 50% increase in 
the detection of respiratory viruses was reported when using 
multiplex RT-PCR methods compared to conventional 
methods, such as viral culture or direct fluorescent 
antibodies (44). Commercial multiplex PCR kits, cleared 
by the Food and Drug Association (FDA), have become 
available, although they offer mixtures of pros and cons (45). 
Among them, the FilmArray system (BioFire Diagnostics, 
Inc.)—integrating nucleic acid extraction, nested PCR, 
and data analysis in a disposable pouch—enables HMPV 
detection. This system is recommended considering its 
short hands-on and run time, and reagent storage condition 
(room temperature). Limitations of the FilmArray system 
(such as the ability to only perform a single test per run) 
should also be considered when selecting an instrument(s) 
suitable for a clinical laboratory (45-47).
Introducing multiple primer and probe sets can enable 
the detection of multiple viral pathogens; however, 
the potential for reduced amplification efficiency 
exists. Separating the PCR amplification step from the 
hybridization and detection steps solve problems associated 
with diagnostic efficiency and enhances the capacity for 
detecting a broader array of pathogens. These separate 
hybridization techniques have become a forerunner of 
array-based methods. Microarrays comprise collections of 
microscopic DNA or RNA spots bound to a solid surface, 
with the potential of analyzing complex amplified PCR 
products. The microarray substrate can be fabricated from 
nylon, membrane, glass, silicon, or polystyrene microbeads, 
based on probe design and hybridization conditions. 
These microarray-based approaches have proven useful for 
detecting multiple respiratory viruses, including HMPV. 
High‐throughput gene analysis using a dynamic array of 
integrated fluidics chips on the BioMark platform (38,48), or 
the CLART PneumoVir platform from Genomica (49) have 
been utilized for HMPV detection. Furthermore, liquid-
phase, bead-conjugated microarray methods have been 
applied with commercial Luminex systems for detecting 
amplified products. When adding new probes to solid-phase 
microarrays, it is necessary to reformat the procedures and 
print new arrays, although these steps are not required for 
suspension microarrays. Therefore, liquid-phase microarray 
techniques exhibit flexibility in terms of assay design and 
format, rapid hybridization kinetics, and lower cost (50,51). 
The Luminex xTAG RVP fast assay is a multiplexed 
microsphere-based suspension microarray platform that 
enables the analysis and reporting of 12 respiratory viruses 
from nasopharyngeal swabs. Several investigators have 
adopted the commercially available Luminex system for 
HMPV detection (52-54). The Luminex system showed 
higher positivity (47.5%) than real-time RT-PCR (42.5%) 
and immunofluorescence assays (2.7%) (55). However, as 
previously mentioned, the FilmArray system was reported 
to have higher sensitivity than the Luminex xTAG RVP fast 
assay and shorter a run time (1 hour) and hands-on time 
(2 minutes) (45,52). Additional enzymatic amplification 
steps for viral RNA prior to hybridization are required 
for microarray-based methods. Moreover, detection 
requires labeling of multiple probes or the incorporation 
of fluorescent dye- or biotin-conjugated nucleotides into 
cDNA. In addition, the sensitivities of most conventional 
microarrays have depended on the efficiency of target 
amplification and probe hybridization. The multiple 
steps required for these microarrays make them complex, 
expensive, labor-intensive, and vulnerable to contamination. 
These array systems are also prone to false-negative 
results because of the gene mutations, PCR inhibitors, and 
degradation of RNA products. Further investigations are 
required to optimize the design of multiple, virus-specific 
primers and assay systems. 
The  de tec t ion  methods  u sed  and  the i r  ma in 
characteristics observed in previous HMPV studies are 
presented in Table 1. The included studies were mainly based 
on four HMPV meta-analyses recently published in 3 years 
[2017–2019] (45,56-58). Forty-seven studies are included 
to reflect methods used in clinical laboratories. The 
countries/areas included in this study were Belgium (59), 
Botswana (60), Brazil (61), Canada (22), China (23,39,62), 
Denmark (38), Israel (37), Jordan (19,63), Kenya (36), 
Malawi (64), Mexico (48), Mozambique (65,66), New 
Zealand (67), South Africa (18,31,32,68-76), Sweden (77), 
Taiwan (17,78), Thailand (15), Turkey (49), and USA 
(3,7,16,20,21,52-54,79-83). The most frequently used 
method was multiplex PCR (57.4%), followed by real-
time RT-PCR (38.3%) (Figure 1). Commercially available 
products from diverse companies, such as the One-Step RT-
PCR Kit (Applied Biosystems or Qiagen), TaqMan real-
time PCR kits, NucliSENS EasyQ instrument (bioMérieux), 
and Pro hMPV Real Time assay (Gen-Probe) were used to 
detect HMPV. The differences in the assays used to detect 
HMPV according to previous publications are illustrated 
in Figure 2. Multiplex PCR (69.7%) became the most 
commonly used method in 2011–2019, in contrast to 2001–
2009. The advent of multiplex PCR for detecting multiple 
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pathogens (including coinfecting viruses) in a single run 
influenced these changes in user preferences.
Viral culture
The isolation of viruses from culture is considered a gold 
standard for diagnosing infection (52,64). After inoculating 
a permissive cell line with an infectious sample, such as a 
nasopharyngeal swab or aspirate, the specimen is incubated 
for 7 to 10 days to observe the development of a cytopathic 
effect (CPE). CPE refers to structural changes in cells 
caused by viral invasion. Established cell lines, such as 
Madin-Darby canine kidney cells, A549 cells, mink lung 
epithelial cell lines, human lung diploid fibroblast cells 
(MRC-5 and WI-38), HeLa cells, rhesus monkey kidney 
cells (LLC-MK2), and buffalo green monkey kidney cells 
are utilized for isolating diverse viruses, including influenza 
virus and respiratory syncytial virus (52,64,84). Regarding 
HMPV, various cell lines, such as the Vero (85), HEp-
2, Hep G2 (86), 293 (87), and LLC-MK2 (2,7,52) cell 
lines have been used to isolate the virus. Among them, a 
human Chang conjunctiva cell line (clone 1-5C4) and a 
feline kidney CRFK cell line were suggested as the most 
suitable cells for HMPV isolation, based on a previous 
study of 19 different cell lines used to grow HMPV (88). 
HMPV culture in LLC-MK2 cell lines has been frequently 
performed in clinical laboratories, based on previous reports 
(7,52). The tolerance of LLC-MK2 cells to trypsin make it 
an ideal cell line for HMPV cultivation (85).
Traditional viral culture has been generally replaced by 
shell vial culture. This technique involves the inoculation 
of samples onto a cell monolayer in shell vials, followed by 
centrifugation and further incubation. After 24 to 48 hours, 
the HMPV antigens are measured with virus-specific 
antibodies. Shell vial culture enables rapid detection of 
slow-growing viruses, including HMPV. Moreover, this 
method is relatively straightforward and more sensitive than 
traditional viral culture, due to the centrifugation steps (89). 
In addition, a modified shell vial culture method has been 
introduced. This technique, utilizing R-Mix or R-Mix Too 
cells from Diagnostic Hybrids (a mixture of mink lung 
cells and human adenocarcinoma cells), has shown higher 
sensitivity than the shell vial culture method with a run time 
of 1.4 days (80,84).
HMPV grows so slowly that it shows late CPEs varying 
from cell rounding and detachment from the culture matrix 
to the formation of small syncytia (i.e., large cytoplasmic 
masses that contain many nuclei). Therefore, immunoassays 
such as direct fluorescent assays (DFAs) and enzyme-linked 
immunosorbent assays (ELISAs) are frequently utilized 
along with cell culture to detect HMPV antigens (85).
Florescent immunoassay
Among the various florescent immunoassays, DFA testing 
directly determines the presence of specific antigens with 
fluorescently labeled antibodies and has been widely 
employed to detect viruses in clinical laboratories. This 
method involves the direct staining of respiratory epithelial 
cells derived from nasopharyngeal swabs or aspirates with 
fluorescently labeled, virus-specific antibodies (82,90). DFA 
methods coupled with viral culture or shell vial culture are 
also widely used for enhanced sensitivity and specificity (80). 
Data interpretation using immunofluorescence microscopy 
is necessary. Determination of the correct absorption 
wavelength is required to excite the fluorophore tag bound 
to the antibody and detect the released fluorescence, 
where positive cells are indicated by the presence of 
the targeted virus. DFAs have been used for several 
decades due to their simplicity and short turnaround 
Figure 1  Applied laboratory assays for detecting human 
metapneumovirus. (A) Pie charts showing the use of PCR-
based assays. (B) Pie charts showing the use of viral culture and 
immunoassays. RT-PCR, reverse transcriptase polymerase chain 
reaction.
Detection method: PCR 
Detection method: other methods 
Multiplex PCR
Real-time RT-PCR 
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time. A modified cytospin-enhanced DFA has also 
been used to enhance the sensitivity in terms of virus 
detection. Cytospinning decreases inadequate smears 
and improves cell morphology, resulting in enhanced 
performance. Data from a previous study showed that 
85.4% (41/48) of samples were positive by cytospin-
enhanced DFA, compared to TaqMan RT-PCR (91). 
Among commercially available DFA kits approved by the 
FDA, the D3 DFA test (Diagnostic Hybrids) has been 
widely used (44,80). This kit enables the identification of 
HMPV in less than 25 minutes after sample receipt and 
shows high sensitivity (95.2%) and specificity (100%) 
compared to RT-PCR (92). When compared to shell vial 
culture, DFA showed comparable results (93.3%) based on 
the number of positive samples determined by RT-PCR (93). 
In another study, comparing viral culture with DFA showed 
a 92% sensitivity and a 90% specificity for HMPV (80). 
However, no recent studies have involved HMPV detection 
without molecular techniques because of the shorter 
turnaround times and higher sensitivity of molecular tools.
The assays used and their main characteristics in studies 
involving viral culture and fluorescent immunoassays 
are shown in Table 1. Among 47 included studies, 8 
studies (17.0%) involved viral culture and fluorescent 
immunoassays, whereas the remaining 39 studies (83.0%) 
employed only PCR-based methods for HMPV detection 
(Figure 1). LLC-MK2 cells (Diagnostic Hybrids) have 
been frequently used for HMPV culture in several clinical 
laboratories (7,52). The usefulness of trypsin-tolerant 
LLC-MK2 cells for HMPV cultivation has influenced 
these trends (85). In terms of DFAs, the FDA-approved D3 
DFA kit from Diagnostic Hybrids have been widely used 
(44,80). The short turnaround time (less than 25 minutes) 
and high performance compared to RT-PCR make it 
commonly utilized. Changes over time in the use of culture 
and fluorescent immunoassays for detecting HMPV are 
presented in Figure 2. The combined proportions of 
culture-based and fluorescent immunoassays decreased from 
21.4% in 2001–2010 to 15.2% in 2011–2019. Meanwhile, 
PCR-based methods showed an increasing trend (78.6% 
in 2001–2010 versus 84.8% in 2011–2019). These changes 
might have occurred because PCR methods such as RT-
Figure 2 Changes in the application of laboratory assays for detecting human metapneumovirus over time. (A) Pie charts showing changes 
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PCR and multiplex PCR demonstrated better diagnostic 
performances (45). In a previous study, the sensitivity and 
specificity of viral culture were reported to be 68% and 
99%, respectively, as compared to real-time RT-PCR 
detection of HMPV (94). In addition, the shorter run- and 
hands-on times, and more reliable results than traditional 
methods make PCR techniques preferable tools in many 
clinical laboratories (45).
Other methods
Among traditional methods for detecting HMPV, 
serological assays including virus-neutralization assays 
(95-97) and enzyme immunoassays (7) were once the 
main techniques. Virus-neutralization assays are used to 
detect virus-specific antibodies induced by viral infection. 
Virus-specific antibodies are produced by the immune 
system to neutralize viruses. The titer can be measured 
and the highest serum dilution at which virus infection 
is blocked is considered as the virus-neutralization titer. 
When performing virus-neutralization assays, the hazards 
due to the use of infectious viruses should considered. 
Several studies have been performed to develop better 
neutralization assays for HMPV detection (95-97). Plaque-
reduction, virus-neutralization assays showed faster 
turnaround times and better sensitivities than conventional 
methods requiring around 7 days for completion (95). 
Micro-neutralization assays for measuring antibody 
titers (96) and neutralization assay based on recombinant 
HMPV expressing Renilla luciferase (97) also enabled 
efficient HMPV detection.
In terms of enzyme immunoassays, enzymes are 
conjugated to secondary (detection) antibodies, which bind 
to the primary viral antigen-antibody complex. When the 
appropriate substrate is added and incubated, the enzyme 
catalyzes the production of a colored end-product, which 
can be visualized and quantified. The most frequently used 
enzymes are alkaline phosphatase, horseradish peroxidase, 
and β-galactosidase (98). It is necessary to distinguish specific 
HMPV antigens from nonspecific complexes, for most 
commercially available systems. These systems are known 
as ELISA or solid-phase immunosorbent assays. Separation 
is feasible through binding of the antigen or capturing the 
antibody on a solid material, such as a microtiter plate or 
paper strip. Lysates from representative HMPV strains (7) 
or the carboxy-terminal domain of the N protein of HMPV (99) 
can be used for antigen preparation. Although ELISA-based 
tests have been developed with rapid turnaround times (100) 
and better diagnostic performance than traditional methods, 
PCR-based assays offering higher sensitivity have become 
preferred techniques in clinical laboratories.
In terms of modified PCR-based methods, the PCR-
electrospray ionization mass spectrometry (ESI-MS) 
approach provided by the PLEX-ID system (Abbott 
Laboratories) was applied to detect HMPV. After RT-
PCR, automated post-PCR desalting, ESI-MS signal 
acquisition, spectral analysis, and data reporting can be 
performed on a biosensor platform (Ibis Biosciences, 
USA). Virus identification was based on the MS data and 
base compositions of the PCR amplicons when compared 
to those in the molecular database established by the 
PLEX-ID manufacturer (17,101). Accurate identification 
based on both MS data and base compositions of PCR 
amplicons are an advantage of the ESI-MS technique. 
However, the process involves a longer turnaround time 
from sample to result (within 6 to 8 hours) and is more 
laborious than currently available multiplex RT-PCR 
systems (45). Regarding advanced multiplex RT-PCR 
methods, microarrays using nanoparticles coupled with 
silver staining have been adopted and served as tools for 
detecting viruses. This nanoparticle-based microarray offers 
better sensitivity than fluorescent dyes commonly utilized in 
most microarrays. When combining with next-generation 
sequencing (NGS) technology, this assay can be suitable 
for screening and identifying a broader range of viruses 
with shorter run- and hands-on times, due to the simplified 
procedures (102). This approach has been investigated 
mainly for influenza viruses and further studies with HMPV 
are necessary.
NGS has provided a quantum leap in the field of 
molecular diagnostics. NGS offers significant improvements 
in sequencing speed and throughput due to automated 
streamline workflow and reduces the cost of sequencing. 
Several manufacturer-specific platforms such as the Roche 
454 system and the Illumina MiSeq and HiSeq systems 
(which use different sequencing strategies, reagents, and 
bioinformatics software) have been developed. Among 
them, Illumina’s NGS platforms (employing a sequencing-
by-synthesis approach) have been used to analyze small 
non-coding RNAs of HMPV (103) and HMPV viral 
metagenomics (104).
Conclusions and future perspectives
In conclusion, we reviewed applied laboratory methodologies 
for detecting HMPV, one of the major causes of morbidity 
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and mortality derived from ARI. In clinical laboratories, 
the main methods used for HMPV detection are PCR-
based assays including conventional RT-PCR, multiplex 
RT-PCR, and microarray-based approaches. Viral culture 
such as shell vial assays and fluorescent immunoassays 
(combined with or without culture) were once the major 
methods for detecting HMPV. Comparison of the assays 
using the wide range of available data showed that PCR-
based methods have become the more appreciated 
methods. Although viral culture and immunoassays have 
remained in use as reference methods due to their high 
specificity, PCR-based methods offer shorter run- and 
hands-on times, higher sensitivity, a broader range of 
available viral targets, a lower risk of exposure to virus, 
and economic feasibility, which could have influenced the 
changes in use. When using these assays, it is important 
to have a comprehensive understanding of the associated 
principles, advantages, disadvantages, and precautions for 
data interpretation.
Sophisticated techniques for detecting HMPV including 
nanotechnology and biosensors,  with micro-sized 
instruments, ultra-sensitive and specific detectors, faster 
turnaround times, and lowered costs will be developed 
in the future. Furthermore, rapid and accurate diagnosis 
based on the advent of newly developed methods for 
differentiating subtypes and emerging viral variants resistant 
to currently used therapies will greatly benefit patients with 
HMPV infections. In addition, the genetic profiling of 
putative virulence factors and antiviral resistance markers 
using molecular tools such as NGS might improve patient 
prognosis and increase the accuracy in predicting responses 
to therapeutic intervention. Analytical and clinical validation 
should be conducted before using each new technique in 
clinical laboratories.
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